Henry Schein

HSIC

Market cap $8.29B

Overview Fund Activity

67.37 USD

-1.02

1.49%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

67.49

+0.12

0.18%

1 day

-1.49%

5 days

-0.06%

1 month

0.22%

3 months

-3.98%

6 months

-6.17%

Year to date

-1.72%

1 year

-5.43%

5 years

7.19%

10 years

24.44%

About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Employees: 25,000

Healthcare Medical Distribution

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

843% more call options, than puts

Call options by funds: $175M | Put options by funds: $18.5M

18% more funds holding in top 10

Funds holding in top 10: 11 [Q1] → 13 (+2) [Q2]

14% more capital invested

Capital invested by funds: $8.69B [Q1] → $9.91B (+$1.22B) [Q2]

10% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 67

9.46% more ownership

Funds ownership: 102.2% [Q1] → 111.66% (+9.46%) [Q2]

0% more funds holding

Funds holding: 552 [Q1] → 552 (+0) [Q2]

17% less repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 221

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$70

4% upside

Avg. target

$75

11% upside

High target

$83

23% upside

7 analyst ratings

3 positive

43%

4 neutral

57%

0 negative

0%

Evercore ISI Group Elizabeth Anderson	$83	Outperform Upgraded	26 Aug 2025
JP Morgan Rachel Vatnsdal	$76	Overweight Maintained	7 Aug 2025
UBS Kevin Caliendo	$70	Neutral Maintained	6 Aug 2025
Evercore ISI Group Ross Muken	$70	In-Line Maintained	6 Aug 2025
Barrington Research Michael Petusky	$78	Outperform Maintained	6 Aug 2025
Stifel Jonathan Block	$75	Hold Downgraded	25 Jul 2025
Baird Jeff Johnson	$72	Neutral Downgraded	14 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 8 articles about HSIC published over the past 30 days

Pearl Joins Henry Schein One API Exchange as an Authorized Integration Vendor

LOS ANGELES--(BUSINESS WIRE)-- #ArtificialIntelligence--Pearl joins Henry Schein One API Exchange, integrating with Dentrix and Dentrix Ascend to deliver secure AI tools that boost efficiency and care.

Pearl Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript

Henry Schein, Inc. (NASDAQ:HSIC ) Baird Global Healthcare Conference 2025 September 10, 2025 10:50 AM EDT Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Tom Popeck - Chief Executive Officer of Henry Schein Products Group Ronald South - Senior VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.

Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript

Henry Schein Announces $750 Million Share Repurchase Plan

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock. This program is in addition to the $500 million repurchase program announced in January 2025, which is anticipated to be fully executed by the end of the first quarter of 2026. T.

Henry Schein Announces $750 Million Share Repurchase Plan

Henry Schein Medical Expands SolutionsHub with Colaborate

Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories.

Henry Schein Medical Expands SolutionsHub with Colaborate

Henry Schein, Inc. (HSIC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Henry Schein, Inc. (NASDAQ:HSIC ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:00 AM EDT Company Participants Ronald South - Senior VP & CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Presentation Vikramjeet Chopra Associate Equity Analyst Okay. Good morning, everyone.

Henry Schein, Inc. (HSIC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Worldpay & Henry Schein One: Exclusive Partnership Powers Dental Practices

CINCINNATI--(BUSINESS WIRE)--Today, Worldpay® announced it will continue as the exclusive provider of embedded payments for Henry Schein One in a long-term agreement. Since 2004, Worldpay has been the trusted payments partner to Henry Schein One, North America's leading dental software provider serving more than 75,000 practices. This partnership has elevated Henry Schein One's payments business into a powerful driver of revenue and growth while enhancing the experience for its clients and thei.

Worldpay & Henry Schein One: Exclusive Partnership Powers Dental Practices

Henry Schein to Participate in Upcoming Investor Conferences in September

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Wells Fargo Healthcare Conference at the Encore Boston hotel, Boston, MA, on September 4, 2025, at 11:00 a.m. EST. Baird Global Healthcare Conference at the InterContinental hotel, New York City, on September 10, 2025, at 10:50 a.m. EST. Bank o.

Henry Schein to Participate in Upcoming Investor Conferences in September

Henry Schein's 28th Annual ‘Back to School' Program Supports Students Worldwide

MELVILLE, N.Y.--(BUSINESS WIRE)--For the 28th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its “Back to School” program, a flagship initiative of Henry Schein Cares, the Company's global corporate citizenship program. Team Schein Members (TSMs) at 45 locations in the U.S., Canada, Italy, Spain, the U.K., and Ireland are helping more than 5,200 students gain confidence and excitement for the school year. Since 1998, H.

Henry Schein's 28th Annual ‘Back to School' Program Supports Students Worldwide

Henry Schein: The Case For An Upgrade From Hold To Buy

Henry Schein is transitioning to higher-margin businesses, with strong tailwinds in dental and medical markets, and is now fairly valued after previous overvaluation. KKR's strategic investment and restructuring support, plus resolution of past issues like the cyber incident, position HSIC for margin improvement and renewed growth. Despite recent stagnation, margin compression, and tariff headwinds, management is actively addressing challenges through efficiency initiatives and product mix shifts.

Henry Schein: The Case For An Upgrade From Hold To Buy

The Motley Fool

Henry Schein (HSIC) Q2 EPS Drops 11%

Henry Schein (HSIC) Q2 EPS Drops 11%

Henry Schein (HSIC) Q2 EPS Drops 11%

See News Rankings

Charts implemented using Lightweight Charts™